Patents

Intellectual Property

Intellectual Property » Patents

When the stakes are high, companies need the best strategic advice and a highly capable team who can build on work done in other jurisdictions, not reinvent the wheel, look for clever ways of reducing the burden of litigation through novel approaches to discovery and case management, and focus on the real-issues, not point-scoring. This is what is required as the Courts look towards more efficient resolution of patent disputes through interventionist case management. This is the Corrs approach – backed up by in-house expertise from chemistry to computer science.

Our Experts

Fixler David CMYK 90x130

David Fixler

Partner Location Melbourne Profile
WHEELAHAN Frances website grey SIZED TH

Frances Wheelahan

Partner Location Melbourne Profile
MANDELBAUM Jacky website grey TH

Jacky Mandelbaum

Special Counsel Location Melbourne Profile
CAMERON James website grey SIZED TH

James Cameron

Special Counsel Location Brisbane Profile
Hay Kate website grey SIZED TH

Kate Hay

Partner Location Melbourne Profile
Odette Gourley.jpg

Odette Gourley

Partner Location Sydney Profile
Stephen Stern.jpg

Stephen Stern

Partner Location Melbourne Profile

Our Experience

Corrs called in to protect patents

For UK-based Deb Group, a leading supplier of skin care and hygiene products, protecting its product patents is critical.

When Deb Group sought to challenge US-based hygiene giant Kimberly-Clark over an alleged patent breach, they called on Corrs to advise and manage the dispute process.

More

GE secures water filtration patents

When Siemens brought one of its international disputes with GE concerning water filtration patents to Australia, GE turned to Corrs to assist in a series of related patent oppositions.

The tactics led to GE beating Siemens’ opposition first in the Patents Office and then in subsequent Federal Court appeals, in order to secure a granted patent.

Corrs is now asserting GE’s patent through infringement proceedings against Siemens whilst Siemens’ unsuccessful oppositions to other patent applications are dealt with through the appeals process.

More

Major victory for global pharmaceutical company

When two leading Australian generic drug manufacturers challenged the patent for the antidepressant, Lexapro, the landmark Australian case raised questions of chemistry, regulatory data and patent term extensions.

Corrs represented patent owner Lundbeck, a major global pharmaceutical company based in Denmark. Our work required close collaboration with the in-house counsel of the Danish research company, US and British lawyers to co-ordinate strategy and the use of expert witnesses in more than one jurisdiction to secure a victory in the only case of its kind upheld by Australian Courts.

More

Pharmathen patent victory over global giant

Corrs represented Pharmathen, a major European manufacturer of ingredients used in generic pharmaceuticals, in a landmark case that saw Pharmathen retain its Australian market presence.

Corrs’ IP team successfully challenged Wyeth (Pfizer’s) injunction restraining Pharmathen entering the Australian market with a generic pharmaceutical.

After a significant contest and on appeal to the Full Court, the victory saw the High Court rejected Pfizer’s application for special leave to appeal and revoked their patent.

More

Our Thinking

Change in the air for IP laws in Australia: 5 key takeaways

The Government has responded to the Productivity Commission’s review of Australia’s IP system. Here are five key takeaways.

More

Software patents will not crash the patent system

In November last year, the Court had an opportunity to consider whether software patents were patentable subject matter under the Patents Act 1990.

More

The key to prolonging patent royalty streams

Australian policy makers should amend the Patents Act to account for the growing trend of ‘patent pooling’.

More

Australia’s innovation patent system: Reform is still on the cards

Is Australia’s powerful innovation patent system under threat?

More

Protect your innovative technology-driven methods: Federal Court clarifies scope of IP protection

A recent case has confirmed that computer-implemented methods can be patentable.

More

Federal Court considers the new patent entitlement provisions for the first time

In a recent interlocutory injunction proceeding before his Honour Justice Rares in the Federal Court the new patent entitlement provisions of the Patents Act 1990 (Cth) were considered, it is understood, for the first time.

More

IP for free? A ‘Quirky’ idea that reinvents innovation

Companies spend billions protecting their IP, but now one of the world’s largest is bucking the trend and giving free access to some of its patents.

More

Pharma patents review draft report - A hard pill for innovators to swallow

On 15 October 2012, the Government announced that a Panel had been appointed to conduct a review of pharmaceutical patents.

More

A 'duty to invent' some things, but not others - Royal Children’s Hospital v Robert Alexander

The Australian Patents Office recently considered an application brought by the Royal Children’s Hospital under sections 32 and 36 of the Patents Act 1990.

More Download

Federal Government keen to ensure that the Australian public has access to essential technology

The Productivity Commission is to review patent compulsory licensing powers.

More

Do you have the tactical and strategic edge in litigation?

From time to time you will be faced with a step which is unusual and not generally taken by lawyers. But if followed in the appropriate way it can save the client considerable time and money.

More

Australia should lead in counterfeit crackdown

The new Anti-counterfeiting Trade Agreement (ACTA) is the latest international effort aimed at combating the more than US$200 billion dollar global trade in counterfeit and pirated goods.

More

Our Experience

Corrs called in to protect patents

For UK-based Deb Group, a leading supplier of skin care and hygiene products, protecting its product patents is critical.

When Deb Group sought to challenge US-based hygiene giant Kimberly-Clark over an alleged patent breach, they called on Corrs to advise and manage the dispute process.

GE secures water filtration patents

When Siemens brought one of its international disputes with GE concerning water filtration patents to Australia, GE turned to Corrs to assist in a series of related patent oppositions.

The tactics led to GE beating Siemens’ opposition first in the Patents Office and then in subsequent Federal Court appeals, in order to secure a granted patent.

Corrs is now asserting GE’s patent through infringement proceedings against Siemens whilst Siemens’ unsuccessful oppositions to other patent applications are dealt with through the appeals process.

Major victory for global pharmaceutical company

When two leading Australian generic drug manufacturers challenged the patent for the antidepressant, Lexapro, the landmark Australian case raised questions of chemistry, regulatory data and patent term extensions.

Corrs represented patent owner Lundbeck, a major global pharmaceutical company based in Denmark. Our work required close collaboration with the in-house counsel of the Danish research company, US and British lawyers to co-ordinate strategy and the use of expert witnesses in more than one jurisdiction to secure a victory in the only case of its kind upheld by Australian Courts.

Pharmathen patent victory over global giant

Corrs represented Pharmathen, a major European manufacturer of ingredients used in generic pharmaceuticals, in a landmark case that saw Pharmathen retain its Australian market presence.

Corrs’ IP team successfully challenged Wyeth (Pfizer’s) injunction restraining Pharmathen entering the Australian market with a generic pharmaceutical.

After a significant contest and on appeal to the Full Court, the victory saw the High Court rejected Pfizer’s application for special leave to appeal and revoked their patent.

Our Thinking

Change in the air for IP laws in Australia: 5 key takeaways

The Government has responded to the Productivity Commission’s review of Australia’s IP system. Here are five key takeaways.

Software patents will not crash the patent system

In November last year, the Court had an opportunity to consider whether software patents were patentable subject matter under the Patents Act 1990.

The key to prolonging patent royalty streams

Australian policy makers should amend the Patents Act to account for the growing trend of ‘patent pooling’.

Australia’s innovation patent system: Reform is still on the cards

Is Australia’s powerful innovation patent system under threat?

Protect your innovative technology-driven methods: Federal Court clarifies scope of IP protection

A recent case has confirmed that computer-implemented methods can be patentable.

Federal Court considers the new patent entitlement provisions for the first time

In a recent interlocutory injunction proceeding before his Honour Justice Rares in the Federal Court the new patent entitlement provisions of the Patents Act 1990 (Cth) were considered, it is understood, for the first time.

IP for free? A ‘Quirky’ idea that reinvents innovation

Companies spend billions protecting their IP, but now one of the world’s largest is bucking the trend and giving free access to some of its patents.

Pharma patents review draft report - A hard pill for innovators to swallow

On 15 October 2012, the Government announced that a Panel had been appointed to conduct a review of pharmaceutical patents.

A 'duty to invent' some things, but not others - Royal Children’s Hospital v Robert Alexander

The Australian Patents Office recently considered an application brought by the Royal Children’s Hospital under sections 32 and 36 of the Patents Act 1990.

Federal Government keen to ensure that the Australian public has access to essential technology

The Productivity Commission is to review patent compulsory licensing powers.

Do you have the tactical and strategic edge in litigation?

From time to time you will be faced with a step which is unusual and not generally taken by lawyers. But if followed in the appropriate way it can save the client considerable time and money.

Australia should lead in counterfeit crackdown

The new Anti-counterfeiting Trade Agreement (ACTA) is the latest international effort aimed at combating the more than US$200 billion dollar global trade in counterfeit and pirated goods.

Our Experts

Fixler David CMYK 90x130

David Fixler

Partner Melbourne +61 3 9672 3173
WHEELAHAN Frances website grey SIZED TH

Frances Wheelahan

Partner Melbourne +61 3 9672 3380
MANDELBAUM Jacky website grey TH

Jacky Mandelbaum

Special Counsel Melbourne +61 3 9672 3488
CAMERON James website grey SIZED TH

James Cameron

Special Counsel Brisbane +61 7 3228 9752
Hay Kate website grey SIZED TH

Kate Hay

Partner Melbourne +61 3 9672 3155
Odette Gourley.jpg

Odette Gourley

Partner Sydney +61 2 9210 6066
Stephen Stern.jpg

Stephen Stern

Partner Melbourne +61 3 9672 3148